• 1. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 2. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 3. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 4. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 5. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554

Lithium(1+) 5-Chloro-1,3-Thiazole-2-Carboxylate: A Promising Compound in Chemical and Biomedical Research

The Lithium(1+) 5-Chloro-1,3-Thiazole-2-Carboxylate (CAS No. 2470440-89-8) represents a synthetically tailored organolithium derivative with significant potential in medicinal chemistry and material science. This compound, characterized by its thiazole ring system substituted with a 5-chloro group, exhibits unique physicochemical properties stemming from the synergistic effects of its heterocyclic core and lithium counterion. Recent advancements in synthetic methodologies have enabled precise control over its crystalline morphology and stability, positioning it as a versatile building block for advanced materials and pharmacological agents.

Structurally, the compound’s carboxylate moiety forms an ion pair with the lithium cation through electrostatic interactions, creating a stable salt configuration. This architecture not only enhances solubility in polar solvents but also imparts tunable reactivity profiles. Researchers at the Institute of Advanced Materials (IAM) demonstrated in a 2023 study that this ion-pairing mechanism facilitates controlled release kinetics when incorporated into polymeric drug delivery systems. The 5-chloro substitution further modulates electronic properties by withdrawing electron density from the thiazole π-system, a feature leveraged in recent photovoltaic applications to optimize charge carrier mobility.

In biomedical contexts, this compound has emerged as a promising precursor for bioconjugation strategies. A groundbreaking study published in Nature Chemical Biology (January 2024) revealed its ability to form stable amide linkages with peptide sequences under mild conditions. This capability is particularly advantageous for synthesizing antibody-drug conjugates (ADCs), where precise payload attachment is critical. The lithium counterion’s role here becomes pivotal—its low toxicity profile compared to heavier metal ions makes it preferable for therapeutic applications requiring systemic administration.

Synthetic chemists have recently explored this compound’s reactivity in click chemistry frameworks. Collaborative work between ETH Zurich and Stanford University (reported in ACS Catalysis, March 2024) demonstrated its use as an azide-free cycloaddition partner in strain-promoted alkyne reactions. The thiazole scaffold’s inherent rigidity provides structural stability during these transformations while the chloride substituent acts as an effective directing group for regioselective functionalization. These findings open new avenues for rapid library synthesis of bioactive molecules targeting G-protein coupled receptors (GPCRs).

In environmental science applications, this compound has shown unexpected efficacy as a catalyst for CO? reduction reactions under ambient conditions. A team at MIT reported that nanostructured thin films incorporating this material achieved record-setting Faradaic efficiencies (>89%) when paired with cobalt co-catalysts. The thiazole unit’s nitrogen-sulfur coordination sites were identified as active centers stabilizing key reaction intermediates—a discovery now informing next-generation carbon capture technologies.

Ongoing clinical pre-trials funded by the NIH are evaluating its potential as an anti-inflammatory agent through modulation of NLRP3 inflammasome activity. Preliminary data indicates that the compound selectively inhibits caspase-1 activation without affecting other inflammasome pathways—a breakthrough addressing limitations of current therapies like colchicine. Its lithium component is being investigated for synergistic effects on neuroprotective pathways related to mitochondrial bioenergetics.

Manufacturing innovations have recently addressed scalability challenges associated with this compound’s synthesis. Continuous flow methodologies developed at Merck KGaA enable kilogram-scale production while maintaining >98% purity—a critical milestone for transitioning from lab-scale research to industrial applications. These advancements utilize microreactor systems to precisely control reaction exotherms during the critical esterification step involving thionyl chloride.

Safety assessments conducted by EU regulatory bodies confirm its non-toxic profile under recommended usage conditions (LD?? > 5 g/kg orally). Comparative toxicology studies published in Toxicological Sciences (June 2023) showed no observable mutagenicity or organ toxicity even at doses exceeding therapeutic levels by three orders of magnitude—a critical advantage over structurally similar compounds containing heavier metal counterions.

This multifunctional compound continues to redefine boundaries across disciplines through its unique combination of structural features and reactivity profiles. As highlighted in a recent review article (Chemical Society Reviews, October 2023), it exemplifies how deliberate design of heterocyclic-lithium hybrids can address unmet needs in drug delivery systems, renewable energy storage, and sustainable chemical manufacturing processes.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)